Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026
Same author

Prevalence of dual sensory impairment in Australia: a nationally representative population-based survey of Indigenous and non-Indigenous Australians.

The Lancet regional health. Western Pacific·2026
Same author

Health Economic Considerations for the Implementation of Artificial Intelligence-Enabled Diabetic Retinopathy Screening: A Review.

Clinical & experimental ophthalmology·2025
Same author

Diabetic retinopathy screening in Australian general practice: persistently low uptake despite national guidelines and equity initiatives.

Journal of diabetes and metabolic disorders·2025
Same author

Prevalence of refractive error in Indigenous and non-Indigenous Australians: a systematic review and meta-analysis.

BMJ open ophthalmology·2025
Same author

Inherited retinal disease in global Indigenous populations: A scoping review.

Survey of ophthalmology·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Jul 4, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

トラコーマ トラコーマ

Heathcote R Wright1, Angus Turner, Hugh R Taylor

  • 1Centre for Eye Research Australia, University of Melbourne, WHO Collaborating Centre for the Prevention of Blindness, East Melbourne, VIC, Australia. heathcote27@hotmail.com

Lancet (London, England)
|June 10, 2008
PubMed
まとめ
この要約は機械生成です。

"2020年までにトラコーマ全世界の撲滅"は,予防可能な失明の主要な原因であるトラコーマを根絶することを目指しています. SAFE戦略 (外科手術,抗生物質,顔の清潔さ,環境改善) は,この感染症性眼疾患の制御に有効であることが証明されています.

さらに関連する動画

Surgical Correction for Pediatric Epiblepharon and Trichiasis
03:59

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

関連する実験動画

Last Updated: Jul 4, 2026

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

Surgical Correction for Pediatric Epiblepharon and Trichiasis
03:59

Surgical Correction for Pediatric Epiblepharon and Trichiasis

Published on: July 8, 2025

科学分野:

  • オフタルモロジック (眼科)
  • 感染症 感染症は感染症です.
  • 公衆衛生は公衆衛生である.

背景:

  • トラコマは,クラミジア・トラコマティスによって引き起こされる角膜膜炎であり,傷痕や失明につながる.
  • アクティブ・トラコーマは8400万人に罹患しており,そのうちの130万人が末期疾患で失明しています.
  • 繰り返し起こる眼感染症は,結膜の傷跡,眼の歪み,角膜の擦り傷を引き起こします.

研究 の 目的:

  • 2020年までにトラコーマの世界的な撲滅イニシアチブの有効性を評価する.
  • トラコーマの制御と除去に対するSAFE戦略の影響を評価する.
  • 2020年までに失明性トラコーマの潜在的絶滅を予測する.

主な方法:

  • SAFE戦略に基づくコミュニティレベルでの介入: トリキアシスの手術, 活性トラコーマの抗生物質, 顔の清潔さ, 環境改善.
  • 人口保健イニシアチブを支持する証拠のレビュー.
  • トラコマ撲滅に向けた世界的な取り組みを監視する.

主要な成果:

  • SAFE戦略は,トラコーマの制御に有効性を示しています.
  • 継続的な世界的な努力は,2020年の撲滅目標を達成するために不可欠です.
  • 証拠は,さらなる症例と失明を予防するためのアプローチを支持しています.

結論:

  • トラコーマは2020年までに地球規模でトラコーマを撲滅するイニシアチブによって絶滅の危機に瀕しています.
  • SAFE戦略は,感染性眼疾患の制御のための成功した公衆衛生プログラムです.
  • SAFE戦略の継続的な実施により,2020年までに盲目性トラコーマを撲滅することが期待されています.